Synovial joint biology and pathobiology

Equine Surgery

Volumn , Issue , 2006, Pages 1036-1055

  Frisbie, David D ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882380607     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B1-41-600123-9/50085-1     Document Type: Chapter

References (80)

1. Akeson WH Articular cartilage and its exacting characteristics: The benchmark for all attempts to achieve articular cartilage regeneration or repair. Daniel's Knee Injuries: Ligament and Cartilage Structure, Function, Injury, and Repair 2003, Lippincott Williams & Wilkins, Philadelphia. ed 2. D.M. Daniel, R.A. Pedowitz, J.J. O'Connor (Eds.).
2. Dee R The innervation of joints. The Joints and Synovial Fluid 1978, Academic Press, New York. L. Sokoloff (Ed.).
3. Gronblad M, Korkala O, Liesi P, et al. Innervation of synovial membrane and meniscus. Acta Orthop Scand 1985, 56:484-486.
4. Henderson B, Pettipher ER The synovial lining cell: Biology and pathobiology. Semin Arthritis Rheum 1985, 15:1-32.
5. Norton WL, Lewis DC, Ziff M Electron-dense deposits following injection of gold sodium thiomalate and thiomalic acid. Arthritis Rheum 1968, 11:436-443.
6. Roy S, Ghadially FN, Crane WA Synovial membrane in traumatic effusion: Ultrastructure and autoradiography with tritiated leucine. Ann Rheum Dis 1966, 25:259-271.
7. Todhunter RJ Anatomy and physiology of synovial joints. Joint Disease in the Horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
8. McIlwraith CW General pathobiology of the joint and response to injury. Joint Disease in the Horse 1996, WB Saunders, Philadelphia. ed 1. C.W. McIlwraith, G.W. Trotter (Eds.).
9. Howard RD, McIlwraith CW Hyaluronan and its use in the treatment of equine joint disease. Joint Disease in the Horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
10. Mankin HJ, Radin EL Structure and function of joints. Arthritis and Allied Conditions: A Textbook of Rheumatology 1993, Lea & Febiger, Philadelphia. ed 2. D.J. McCarty (Ed.).
11. McIlwraith CW Diseases of joints, tendons, ligaments, and related structures. Adams' Lameness in Horses 2002, Williams & Wilkins, Philadelphia. ed 5. T.S. Stashak (Ed.).
12. Gamble JG, Edwards CC, Max SR Enzymatic adaptation in ligaments during immobilization. Am J Sports Med 1984, 12:221-228.
13. Ralphs JR, Benjamin M The joint capsule: Structure, composition, ageing and disease. J Anat 1994, 184:503-509.
14. Thornton GM, Shrive NG, Frank CB Healing ligaments have decreased cyclic modulus compared to normal ligaments and immobilization further compromises healing ligament response to cyclic loading. J Orthop Res 2003, 21:716-722.
15. Radin EL, Paul IL, Tolkoff MJ Subchondral bone changes in patients with early degenerative joint disease. Arthritis Rheum 1970, 13:400-405.
16. Richardson DW, Yound DR, Clark CC The relationship of subchondral bone stiffness to overlying cartilage morphology and biochemistry. Orthop Res Soc 1993, 720.
17. Kawcak CE, McIlwraith CW, Norrdin RW, et al. Clinical effects of exercise on subchondral bone of carpal and metacarpophalangeal joints in horses. Am J Vet Res 2000, 61:1252-1258.
18. Teshima R, Otsuka T, Takasu N, et al. Structure of the most superficial layer of articular cartilage. J Bone Joint Surg Br 1995, 77:460-464.
19. Frisbie DD, Trotter GW, Powers BE, et al. Arthroscopic subchondral bone plate microfracture technique augments healing of large chondral defects in the radial carpal bone and medial femoral condyle of horses. Vet Surg 1999, 28:242-255.
20. McCutchen C The frictional properties of animal joints. Wear 1962, 5:1.
21. Hultkrantz W Uber die Spaltrichtungen der Gelenkknorpel. Verh Anat Ges 1898, 12:248.
22. Pauwels F Structure of the tangential fibrous layer of the articular cartilage in the scapular glenoid cavity as an example of an unsubstantiated strain field. Z Anat Entw Gesch 1959, 121:188.
23. van der Rest M, Garrone R Collagen family of proteins. FASEB J 1991, 5:2814-2823.
24. Vachon AM, Keeley FW, McIlwraith CW, et al. Biochemical analysis of normal articular cartilage in horses. Am J Vet Res 1990, 51:1905-1911.
25. Kielty CM, Whittaker SP, Grant ME, et al. Type VI collagen microfibrils: Evidence for a structural association with hyaluronan. J Cell Biol 1992, 118:979-990.
26. Stallcup WB, Dahlin K, Healy P Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J Cell Biol 1990, 111:3177-3188.
27. Eikenberry EF, Mendler M, Burgin R, et al. Fibrillar organization in cartilage. Articular Cartilage and Osteoarthritis 1992, Raven Press, New York. K.E. Kuettner, R. Schleyerbach, J.G. Peyron (Eds.).
28. Ogston A The biological functions of the glycosaminoglycans. Chemistry and Molecular Biology of the Intercellular Matrix 1970, Academic Press, New York. E.A. Balazs (Ed.).
29. Mehmet H, Scudder P, Tang PW, et al. The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly( N-acetyllactosamine) series. Eur J Biochem 1986, 157:385-391.
30. Flannery C, Stanescu V, Morgelin M, et al. Variability in the G3 domain content of bovine aggrecan from cartilage extracts and chondrocyte cultures. Arch Biochem Biophys 1992, 297:52-60.
31. Lohmander S Proteoglycans of joint cartilage: Structure, function, turnover and role as markers of joint disease. Baillieres Clin Rheumatol 1988, 2:37-62.
32. March L Articular cartilage in health and disease. The Musculoskeletal System 2001, Churchill Livingstone, New York. P. Sambrook (Ed.).
33. Frisbie DD, Al-Sobayil F, Billinghurst RC, et al. Serum biomarkers distinguish exercise from osteoarthritic pathology. Osteoarthritis Cartilage 2001, 10(Suppl A):S53.
34. Ekman L, Nilsson G, Persson L, et al. Volume of the synovia in certain joint cavities in the horse. Acta Vet Scand 1981, 22:23-31.
35. Delahay JN Biomechanics and biomaterials. Principles of Orthopaedic Medicine and Surgery 2001, WB Saunders, Philadelphia. S.W. Wiesel, J.N. Delahay (Eds.).
36. Mow VC, Hung CT Biomechanics of articular cartilage. Basic Biomechanics of the Musculoskeletal System 2001, Lippincott Williams & Wilkins, Philadelphia. ed 3. M. Nordin, V.H. Frankel (Eds.).
37. Caron JP Osteoarthritis. Diagnosis and Management of Lameness in the Horse 2003, WB Saunders, Philadelphia. M.W. Ross, S.J. Dyson (Eds.).
38. Knowlton RG, Katsenstein PL, Moskowitz RW, et al. Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N Engl J Med 1990, 322:526-530.
39. Frisbie DD, Kawcak CE, Trotter GW, et al. The effects of 6-alpha methylprednisolone acetate on an in vivo equine osteochondral fragment exercise model. Am J Vet Res 1998, 12:1619-1628.
40. Altman RD, Tenenbaum J, Latta L, et al. Biomechanical and biochemical properties of dog cartilage in experimentally induced osteoarthritis. Ann Rheum Dis 1984, 43:83-90.
41. Curtin WA, Reville WJ Ultrastructural observations on fibril profiles in normal and degenerative human articular cartilage. Clin Orthop 1995, 224-230.
42. Maroudas A, Ziv I, Weisman N, et al. Studies of hydration and swelling pressure in normal and osteoarthritic cartilage. Biorheology 1985, 22:159-169.
43. Little CB, Flannery CR, Hughes CE, et al. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999, 344:61-68.
44. Woessner JF MMPs and TIMPs: An historical perspective. Mol Biotechnol 2002, 22:33-49.
45. Okada Y, Shinmei M, Tanaka O, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992, 66:680-690.
46. Caron JP, Tardif G, Martel-Pelletier J, et al. Modulation of matrix metalloprotease 13 (collagenase 3) gene expression in equine chondrocytes by interleukin 1 and corticosteroids. Am J Vet Res 1996, 57:1631-1634.
47. Billinghurst RC, Dahlberg L, Ionescu M, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997, 99:1534-1545.
48. Billinghurst RC, O'Brien K, Poole AR, et al. Inhibition of articular cartilage degradation in culture by a novel nonpeptidic matrix metalloproteinase inhibitor. Ann N Y Acad Sci 1999, 878:594-597.
49. Trumble TN, Trotter GW, Oxford JR, et al. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Am J Vet Res 2001, 62:1467-1477.
50. Yaron I, Meyer FA, Dayer JM, et al. Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum 1989, 32:173-180.
51. Meyer FA, Yaron I, Yaron M Synergistic, additive, and antagonistic effects of interleukin-1 beta, tumor necrosis factor alpha, and gamma-interferon on prostaglandin E, hyaluronic acid, and collagenase production by cultured synovial fibroblasts. Arthritis Rheum 1990, 33:1518-1525.
52. Martel-Pelletier J, Alaaeddine N, Pelletier JP Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 1999, 4:D694-D703.
53. Malemud CJ, Islam N, Haqqi TM Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 2003, 174:34-48.
54. Steinmeyer J Cytokines in osteoarthritis-current status on the pharmacological intervention. Front Biosci 2004, 9:575-580.
55. Cao M, Westerhausen-Larson A, Niyibizi C, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: Prolyl hydroxylase as a possible target. Biochem J 1997, 324:305-310.
56. Oh M, Fukuda K, Asada S, et al. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular chondrocytes: Involvement of peroxynitrite. J Rheumatol 1998, 25:2169-2174.
57. Frisbie DD, McIlwraith CW Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis. Clin Orthop 2000, S273-S287.
58. Moreland LW Inhibitors of tumor necrosis factor for rheumatoid arthritis. J Rheumatol Suppl 1999, 57:7-15.
59. Su S, Grover J, Roughley PJ, et al. Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol Int 1999, 18:183-191.
60. Zafarullah M, Su S, Martel-Pelletier J, et al. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA is constitutively expressed in bovine, human normal, and osteoarthritic articular chondrocytes. J Cell Biochem 1996, 60:211-217.
61. Dean DD, Azzo W, Martel-Pelletier J, et al. Levels of metalloproteases and tissue inhibitor of metalloproteases in human osteoarthritic cartilage. J Rheumatol 1987, 14:43-44.
62. Dean DD, Martel-Pelletier J, Pelletier JP, et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989, 84:678-685.
63. Baker AH, Edwards DR, Murphy G Metalloproteinase inhibitors: Biological actions and therapeutic opportunities. J Cell Sci 2002, 115:3719-3727.
64. Creamer P Osteoarthritis. Textbook of Pain 1999, Churchill Livingstone, New York. ed 4. P.D. Wall, R. Melzack (Eds.).
65. Caron JP, Bowker RM, Abhold RH, et al. Substance P in the synovial membrane and fluid of the equine middle carpal joint. Equine Vet J 1992, 24:364-366.
66. Lotz M, Carson DA, Vaughan JH Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis. Science 1987, 235:893-895.
67. Marshall KW, Chiu B, Inman RD Substance P and arthritis: Analysis of plasma and synovial fluid levels. Arthritis Rheum 1990, 33:87-90.
68. Chamberlain MA, Care G, Harfield B Physiotherapy in osteoarthrosis of the knees: A controlled trial of hospital versus home exercises. Int Rehabil Med 1982, 4:101-106.
69. Dekker J, Tola P, Aufdemkampe G, et al. Negative affect, pain and disability in osteoarthritis patients: The mediating role of muscle weakness. Behav Res Ther 1993, 31:203-206.
70. Fisher NM, Gresham GE, Abrams M, et al. Quantitative effects of physical therapy on muscular and functional performance in subjects with osteoarthritis of the knees. Arch Phys Med Rehabil 1993, 74:840-847.
71. Baxter GM Subchondral cystic lesions in horses. Joint Disease in the Horse 1996, WB Saunders, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
72. Tulamo RM, Houttu J, Tupamaki A, et al. Hyaluronate and large molecular weight proteoglycans in synovial fluid from horses with various arthritides. Am J Vet Res 1996, 57:932-937.
73. Frisbie DD, Ray CS, Ionescu M, et al. Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses. Am J Vet Res 1999, 60:306-309.
74. Denoix J-M The equine distal limb: Atlas of clinical anatomy and comparative imaging 2000, Iowa State University Press, Ames.
75. Hunter W Of the structure and diseases of articulating cartilages. Philosoph Trans 1743, 470:514-521.
76. Convery FR, Akeson WH, Keown GH The repair of large osteochondral defects. Clin Orthop 1972, 82:253-262.
77. Hurtig MB, Fretz PB, Doige CE, et al. Effects of lesion size and location on equine articular cartilage repair. Can J Vet Res 1988, 52:137-146.
78. Dowthwaite GP, Bishop JC, Redman SN, et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci 2004, 117:889-897.
79. Frisbie DD, Oxford JT, Southwood L, et al. Early events in cartilage repair after subchondral bone microfracture. Clin Orthop 2003, 215-227.
80. Kinner B, Spector M Cartilage: Current applications. Orthopedic Tissue Engineering: Basic Science and Practices 2004, Marcel Dekker, New York. A.I. Caplan, V.M. Goldberg (Eds.).